Emerging markets and the complexity of many new treatment scenarios has intensified rivalry for clinical centres. Coupled to this, portfolio diversification often requires companies initiating studies beyond their traditional boundaries or outside their therapeutic comfort zone. The challenge is to liaise with local stakeholders and engineer project success with reliable information. ta-Scan verifies your territories choices and partners. We can help identify individuals or an organization with a specific research pedigree in your chosen country and rank these against alternative country options.
Sign up for our free quarterly newsletter which gives the latest information on our activities, products and market developments.
MDCPartners respects your privacy. You can unsubscribe anytime.